Company Information
 
 
  Stock Code 
 
三生製藥 Code:  01530
3SBIO INC. Website: http://www.3sbio.com
Income Statement
  2025/12
RMB(K$)
Change 2024/12
RMB(K$)
2023/12
RMB(K$)
Turnover17,695,74994.288%9,107,9787,815,938
Operating Profit / (Loss)10,849,602357.953%2,369,1532,008,254
Exceptional Items--------
Profit / (Loss) of Associated Co. & Jointly Controlled Entity(101,512)--348,932(29,795)
Profit / (Loss) before Taxation10,748,090295.429%2,718,0851,978,459
Taxation(1,651,979)--(500,536)(392,167)
Minority Interests(613,947)--(127,229)(37,053)
Profit / (Loss) Attributable to Shareholders8,482,164305.783%2,090,3201,549,239
 
Net Interest Income / (Expense)227,399--(43,065)(59,172)
Depreciation & Amortization542,65931.515%412,622351,462
Directors Remuneration----11,0678,137
 
EPS / (LPS) (cts)351.000308.140%86.00064.000
DPS (cts)22.074-4.324%23.07222.678
 
Dividend Payout Ratio (%)6.289%--26.827%35.434%
NBV Per Share ($)10.72066.369%6.4445.754
Financial Ratio
  2025/12
RMB(K$)
Change 2024/12
RMB(K$)
2023/12
RMB(K$)
Operating Margin (%)61.312%--26.012%25.694%
Interest Coverage Ratio (x)141.709--15.24210.319
ROAA (%)28.057%--8.739%6.790%
ROAE (%)39.781%--14.186%11.493%
 
Copyright ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.